A composition containing antibacterial and acne-reducing cyclic peptides and its application

By using a specific combination of antibacterial acne-reducing cyclic peptides, pansy extract, isatis extract, and saponin extract, the problems of large side effects and poor antibacterial effect of existing acne products are solved. This results in highly effective inhibition of Propionibacterium acnes and Staphylococcus aureus, improving acne symptoms and ensuring skin safety.

CN123058975APending Publication Date: 2026-11-10广州博士派生物科技有限公司 +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611480053.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-22
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

Existing acne treatment products have problems such as significant side effects and poor antibacterial and acne-removing effects. In particular, chemical products are prone to causing skin allergies, and long-term use of antibiotics leads to serious drug resistance in pathogenic bacteria.

Method used

It employs a specific combination of antibacterial and acne-reducing cyclic peptides, pansy extract, isatis extract, and saponin extract to achieve a synergistic antibacterial and acne-reducing effect by disrupting the integrity of bacterial membranes, reducing skin redness and inflammation, inhibiting bacterial growth, and controlling acne.

Benefits of technology

It significantly inhibits Propionibacterium acnes and Staphylococcus aureus, improves acne treatment effect, reduces papule volume and skin inflammation, and is safe and non-irritating to the skin.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
Patent Text Reader

Abstract

This invention belongs to the field of cosmetic technology, specifically relating to a composition containing an antibacterial and acne-reducing cyclic peptide and its application. The composition provided by this invention, by weight, comprises the following components: 7-9 parts of antibacterial and acne-reducing cyclic peptide, 12-17 parts of pansy extract, 5-7 parts of isatis extract, and 15-21 parts of soapberry extract. When these various active ingredients are combined in a specific ratio, they exhibit significant inhibitory effects on both Propionibacterium acnes and Staphylococcus aureus, achieving an antibacterial and acne-reducing effect. When applied to a prepared serum, this composition can improve the improvement rate of papule volume and the improvement rate of a-value, demonstrating excellent acne-reducing effects and effectively meeting consumer needs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of cosmetic technology, specifically relating to a composition containing an antibacterial and acne-reducing cyclic peptide and its application. Background Technology

[0002] Acne is a chronic inflammatory skin disease of the hair follicles and sebaceous glands, often manifesting as comedones, papules, pustules, nodules, and cysts. Studies have found that acne patients have significantly higher levels of Propionibacterium acnes than normal. Propionibacterium acnes can inhibit the biosynthesis of vitamin B12, increase the production of porphyrins, and induce skin inflammation and acne formation. Therefore, inhibiting the growth of Propionibacterium acnes is currently the most important approach to treating acne.

[0003] Currently, many acne treatment products on the market are chemical-based, such as salicylic acid, fruit acid, or retinoic acid. These products are highly irritating and can easily cause skin allergies. While antibiotics can inhibit the growth of microorganisms, long-term use can lead to severe drug resistance in pathogens and may even harm the skin and the body. Compared to antibiotics, plant extracts have advantages such as rich pharmacological effects, fewer side effects, and safety with multiple benefits.

[0004] Acne is a common skin problem. With the popularization of electronic products, the abundance of entertainment facilities, and the increasing pace and pressure of work, developing a gentle composition with excellent antibacterial and acne-removing effects has become an urgent technical problem to be solved in the field of acne technology. Summary of the Invention

[0005] In view of the above-mentioned defects or improvement needs of the prior art, the present invention provides a composition containing antibacterial and acne-removing cyclic peptides and its application, which solves the problems of large side effects and poor antibacterial and acne-removing effects of existing antibacterial and acne-removing skin care products.

[0006] To achieve the above objectives, the present invention adopts the following technical solution: In a first aspect, the present invention provides a composition containing an antibacterial and acne-reducing cyclic peptide, comprising, by weight, the following components: Antibacterial and acne-reducing cyclic peptide: 7-9 parts; Pansy extract: 12-17 parts; Isatis indigotica extract: 5-7 parts; Duck soap tree extract: 15-21 parts.

[0007] The antibacterial acne-removing cyclic peptide of this application includes Bacillus ferment, which can act on the cell membrane of bacteria or fungi and form transmembrane ion channels on the membrane, destroying the integrity of the membrane and causing perforation, causing the cell contents to leak out of the cell and die, inhibiting harmful bacteria, and can effectively reduce the formation of Propionibacterium acnes biofilm and prevent the formation of acne.

[0008] Pansy extract is rich in flavonoids and polyphenols, which can help reduce skin redness, irritation and inflammation, making it suitable for sensitive or acne-prone skin. At the same time, its antioxidant properties can neutralize free radicals, delay skin aging, promote hydration and improve skin barrier function.

[0009] Isatis extract has antibacterial properties, which can inhibit bacterial growth and help control acne and pimple problems; it also has anti-inflammatory and antioxidant properties, which can soothe skin redness and irritation, neutralize free radicals, and delay the skin aging process.

[0010] Soapberry extract can effectively relieve skin inflammation, reduce redness and itching, and has good soothing, moisturizing, and skin-strengthening effects.

[0011] Preferably, the composition comprises, by weight, the following components: Antibacterial and acne-reducing cyclic peptide: 8 parts; Pansy extract: 15 parts; Isatis indigotica extract: 6 parts; Duck soap tree extract: 17 parts.

[0012] Secondly, the present invention provides the use of the composition described in the first aspect in the preparation of cosmetics with antibacterial and acne-removing effects.

[0013] Preferably, the cosmetic is one of the following: toner, lotion, cream, mask, serum, or spray.

[0014] Preferably, the amount of the composition added to the cosmetic is 0.5-10 wt%.

[0015] Thirdly, the present invention provides an essence with antibacterial and acne-removing effects, wherein the essence contains the composition described in the first aspect.

[0016] Preferably, the amount of the composition added to the serum is 1-5 wt%.

[0017] Preferably, the essence further contains at least one of a moisturizer, a thickener, an emulsifier, a preservative, and a solvent.

[0018] The beneficial effects of this invention are: This invention provides a composition containing an antibacterial and acne-reducing cyclic peptide. This composition, through the compounding of the antibacterial and acne-reducing cyclic peptide, pansy extract, isatis extract, and saponin extract, exhibits significant inhibitory effects against both Propionibacterium acnes and Staphylococcus aureus when these active ingredients work synergistically in specific proportions, thus achieving an antibacterial and acne-reducing effect. When this composition is used to prepare a serum, it can improve the improvement rate of papule volume and a-value, demonstrating excellent acne-reducing effects and effectively meeting consumer needs. Detailed Implementation

[0019] To further illustrate the technical means and effects of the present invention in achieving the intended purpose, the following detailed description of the specific embodiments, structure, features and effects of the present invention, in conjunction with the composition, is provided below.

[0020] For the following compositions, unless otherwise specified, experimental methods are generally performed under standard conditions or as recommended by the manufacturer. Unless otherwise specified, all materials and reagents used are commercially available.

[0021] Some of the raw materials and their sources are as follows: The antibacterial and acne-reducing cyclic peptide was purchased from Shanghai Haoyun Trading Co., Ltd., CAS No. 69-65-8; The pansy extract was purchased from Fufeng Sinote Biotechnology Co., Ltd., under the trade name "Pansy Extract", with a product ratio of 20:1. Isatis indigotica extract was purchased from Fufeng Sinote Biotechnology Co., Ltd., under the trade name Isatis indigotica extract, with a product specification of 10:1. The extract of the duck soap tree was purchased from Lanzhou Waterles Biotechnology Co., Ltd., and its product name is duck soap tree extract, with a product specification of 10:1.

[0022] The component composition (parts by weight) of the compositions in Examples 1-3 of this invention is shown in Table 1 below. Each component was weighed according to the formula amount, mixed and homogenized to obtain each composition.

[0023] Table 1. Components and their weight parts of the compositions in Examples 1-3 Example Antibacterial and acne-reducing cyclic peptide (parts by weight) Pansy extract (parts by weight) Isatis indigotica extract (parts by weight) Soapberry extract (parts by weight) 1 7 12 5 15 2 8 15 6 17 3 9 17 7 21 Comparative Example 1 Compared with Example 2, the difference is that the antibacterial and acne-reducing cyclic peptide was not added in Comparative Example 1, and the missing amount was made up by extracts of pansy, isatis extract and saponin tree extract in a weight ratio of 15:6:17. All other conditions and preparation methods were the same as in Example 2.

[0024] Comparative Example 2 Compared with Example 2, the difference is that no pansy extract was added in Comparative Example 2, and the missing amount was made up with antibacterial and acne-reducing cyclic peptide, isatis extract and saponin extract in a weight ratio of 8:6:17. All other conditions and preparation methods are the same as in Example 2.

[0025] Comparative Example 3 Compared with Example 2, the difference is that Isatis indigotica extract was not added in Comparative Example 3. The missing amount was made up with antibacterial and acne-removing cyclic peptide, pansy extract and saponin extract in a weight ratio of 8:15:17. All other conditions and preparation methods were the same as in Example 2.

[0026] Comparative Example 4 Compared with Example 2, the difference is that no saponin extract was added in Comparative Example 4, and the missing amount was made up with antibacterial acne-removing cyclic peptide, pansy extract and isatis extract in a weight ratio of 8:15:6. All other conditions and preparation methods are the same as in Example 2.

[0027] Comparative Example 5 Compared with Example 2, the difference is that in Comparative Example 5, an equal amount of hydrolyzed pansy extract was used instead of pansy extract, while other conditions and preparation methods were the same as in Example 2.

[0028] Comparative Example 6 Compared with Example 2, the difference is that in Comparative Example 6, an equal amount of Isatis root extract was used instead of Isatis extract, while other conditions and preparation methods were the same as in Example 2.

[0029] Comparative Example 7 Compared with Example 2, the difference is that the weight ratio of antibacterial acne-reducing cyclic peptide, pansy extract, isatis extract and saponin extract in Comparative Example 7 is 15:8:6:17, while other conditions and preparation methods are the same as in Example 2.

[0030] Comparative Example 8 Compared with Example 2, the difference is that the weight ratio of antibacterial acne-reducing cyclic peptide, pansy extract, isatis extract and saponin extract in Comparative Example 8 is 8:15:17:6, while other conditions and preparation methods are the same as in Example 2.

[0031] The total weight of each composition in Examples 1-3 is the same as that in Comparative Examples 1-8.

[0032] Example 1: Acne Treatment Test of the Composition This efficacy test example evaluates the acne-removing effects of the compositions prepared in Examples 1-3 and Comparative Examples 1-8 by detecting their inhibition rates against Propionibacterium acnes and Staphylococcus aureus. The tests were conducted in accordance with Appendix C of GB / T 15979-2002 "Hygienic Standard for Disposable Sanitary Products" regarding the test methods for bactericidal, bacteriostatic and stability properties of products. Test strains: The concentration of bacterial suspension was 2.0 × 10⁻⁶. 6 CFU / mL of Propionibacterium acnes and Staphylococcus aureus; Sample preparation: The compositions prepared in Examples 1-3 and Comparative Examples 1-8 were respectively prepared into sample solutions with a mass concentration of 2% using PBS buffer; Specific experimental procedures: For each sample group, 5.0 mL of sample solution was placed in a sterile test tube. 100 μL of test bacteria was added to each test tube, and the mixture was quickly mixed. Timing was started, and the mixture was incubated for 10 min and 20 min. 0.5 mL of the mixture of test bacteria and sample solution was added to a test tube containing 5 mL of sterile PBS buffer and mixed thoroughly. Serial dilutions were performed, and 0.5 mL of each of the 2-3 dilutions was placed in sterile Petri dishes. Two sterile Petri dishes were inoculated for each dilution. 15 mL of nutrient agar medium cooled to 40℃-45℃ was poured into each dish, and the dishes were rotated to ensure thorough mixing. After the agar solidified, the plates were inverted and incubated at (36±1)℃ for (48+2) h. Viable colony counts were then performed. The control group was treated with an equal volume of PBS buffer instead of the sample solution, following the same steps. The experiment was repeated 3 times, and the inhibition rate was calculated using the following formula. The experimental results are shown in Table 2.

[0033] In the formula: X is the inhibition rate; A is the average colony count of the control group; B is the average colony count of the sample group; Evaluation criteria: If the antibacterial rate is ≥50%-90%, the product has antibacterial effect; if the antibacterial rate is ≥90%, the product has strong antibacterial effect. Table 2 Antibacterial rate data

[0034] The experimental results are shown in Table 2. Data from Example 2 and Comparative Examples 1-6 show that, compared to Example 2, Comparative Examples 1-4 did not contain one of the following components: antibacterial acne-removing cyclic peptide, pansy extract, isatis extract, and saponin extract. Comparative Examples 5-6 had pansy extract and isatis extract replaced. Example 2 showed improved antibacterial effects against Propionibacterium acnes and Staphylococcus aureus. This indicates that the combination of antibacterial acne-removing cyclic peptide, pansy extract, isatis extract, and saponin extract exhibits a significant synergistic effect, thus achieving a highly effective acne-removing effect through efficient antibacterial action.

[0035] Based on the data from Examples 1-3 and Comparative Examples 7-8, it can be seen that the composition exhibits better antibacterial effect when the weight ratio of antibacterial acne-reducing cyclic peptide, pansy extract, isatis extract, and saponin extract is (7-9):(12-17):(5-7):(15-21). Furthermore, the composition shows the best effect when the weight ratio of antibacterial acne-reducing cyclic peptide, pansy extract, isatis extract, and saponin extract is 8:15:6:17.

[0036] serum The compositions prepared in Examples 1-3 and Comparative Examples 1-8 were added to the serums to obtain the serums of Application Examples 1-3 and Comparative Application Examples 1-8, respectively.

[0037] The essence comprises the following components by weight percentage: 4% composition, 5% glycerin, 0.5% 1,2-butanediol, 3% sodium hyaluronate, 0.15% carbomer, 2% 1,3-propanediol, 0.2% p-hydroxyacetophenone, 0.5% 1,2-hexanediol, 0.1% fragrance, appropriate amount of EDTA-2Na, and the balance being deionized water.

[0038] The preparation method of the serum specifically includes the following steps: glycerin, 1,2-butanediol, sodium hyaluronate, carbomer, and half the volume of deionized water are mixed and homogenized at 80°C. Then, 1,3-propanediol, p-hydroxyacetophenone, and 1,2-hexanediol are added and stirred until homogeneous to obtain a mixture. The temperature is lowered to 40°C, and the composition, fragrance, and remaining deionized water are added and stirred until homogeneous. Finally, EDTA-2Na is added to adjust the pH to 6 to obtain the serum.

[0039] Blank application example: Compared with application examples 1-3, the difference is that the essence in the blank application example does not contain the composition, and an equal amount of deionized water is used instead of the composition. The preparation method is the same as that in application examples 1-3.

[0040] Example 2: Human Efficacy Test The serums prepared using Application Examples 1-3, Comparative Application Examples 1-8, and Blank Application Examples were used as samples to test their acne-removing effects.

[0041] The testing method is as follows: 96 volunteers with grade 2-3 acne on their faces were recruited, with 8 people in each group; each group of volunteers used the serum obtained from Application Examples 1-3, Control Application Examples 1-8, and Blank Application Example, respectively. After cleansing their faces, 0.5mL of serum was applied and massaged into the skin for absorption, twice a day, morning and evening, for 7 consecutive days. On day 0 and day 7, the reduction in papule volume and the skin a value (a value, which is the redness content of the skin, representing erythema in the dermis and the state of skin inflammation) in the acne-affected areas were measured using a VISA instrument. The improvement rate of papule volume and a value was calculated according to the following formula; the test results are shown in Table 3. ; In the formula: Y 使用前均值 Y represents the average papule volume on day 0 for each group of volunteers; 使用后均值 The average papule volume on day 7 for each group of volunteers; ; In the formula: Z 使用前均值 Z represents the average value of a for each group of volunteers on day 0. 使用后均值 This represents the average value of a for each group of volunteers on day 7. In the formula: Z 使用前均值 Z represents the average value of a for each group of volunteers on day 0. 使用后均值 This represents the average value of a for each group of volunteers on day 7. The experimental results are shown in Table 3. The data on the improvement rate of papule volume and a value of Application Example 2 and Comparative Application Examples 1-6 show that the combination of antibacterial acne-removing cyclic peptide, pansy extract, isatis extract and saponin extract has a significant synergistic effect. Application Example 2 has a better acne-removing and anti-inflammatory effect than Comparative Application Examples 1-6.

[0042] Based on the data on the improvement rates of papule volume and a-value in Application Examples 1-3 and Comparative Application Examples 7-8, it can be concluded that when the weight ratio of antibacterial acne-reducing cyclic peptide, pansy extract, isatis extract, and saponin extract is (7-9):(12-17):(5-7):(15-21), the composition has a better acne-reducing and anti-inflammatory effect when applied to the prepared serum; furthermore, when the weight ratio of antibacterial acne-reducing cyclic peptide, pansy extract, isatis extract, and saponin extract is 8:15:6:17, the serum has the best effect.

[0043] Table 3 Human Efficacy Test Data Group Improvement rate of papule volume (%) Improvement rate of a value (%) Blank application example 2.45 3.71 Application Example 1 18.93 19.50 Application Example 2 20.52 22.47 Application Example 3 17.64 20.58 Comparative Application Example 1 6.39 7.82 Comparative Application Example 2 8.68 9.35 Comparative Application Example 3 7.27 8.79 Comparative Application Example 4 9.65 10.03 Comparative Application Example 5 14.11 15.24 Comparative Application Example 6 13.08 14.57 Comparative Application Example 7 16.32 18.49 Comparative Application Example 8 15.60 17.36 Example 3 of efficacy test: Patch test The serums prepared in Application Examples 1-3 and the blank application example were used as samples to verify their safety on human skin. In accordance with the "Cosmetic Safety Technical Specifications" (2015) for human skin patch testing, 40 volunteers aged 18-50 years were recruited for the experiment. The test environment was a temperature of (21±1)℃ and a humidity of (50±10)%, with 10 people in each group. The volunteers washed their forearms with clean water. After 5-10 minutes, when the moisture on the forearms had evaporated, the testers applied 0.025mL of each sample to each chamber of a 10-well patch tester. The inner sides of the volunteers' two forearms were selected, avoiding the skin at the joints of the front and back of the hands. Each arm was covered with a patch tester and marked accordingly. The patch application time lasted for 24 hours. The patch testers were removed and the residual sample was wiped off. The skin reaction was observed at 0.5h, 24h, and 48h. The test results were recorded according to the adverse skin reaction grading standards in Table 4.

[0044] Table 4. Adverse skin reaction grades Rating levels Skin reaction 0 negative reaction 1 Suspicious reaction, only slight erythema 2 Weak positive reaction (erythema reaction): erythema, infiltration, edema, and papules may be present. 3 Strong positive reaction (herpes reaction): erythema, infiltration, edema, papules; the reaction may extend beyond the test area. 4 Extremely strong positive reaction (confluent herpes simplex reaction): obvious erythema, severe infiltration, edema, confluent herpes simplex; reaction extends beyond the test area. After testing, the essences prepared in Application Examples 1-3 and the blank application examples of this invention showed negative reactions after human patch testing, indicating that they are safe and non-irritating to human skin.

[0045] The above description is merely a preferred composition of the present invention and is not intended to limit the present invention in any way. Although the present invention has been disclosed above with preferred compositions, it is not intended to limit the present invention. Any person skilled in the art can make some modifications or alterations to the above-disclosed technical content to create equivalent compositions without departing from the scope of the present invention. Any simple modifications, equivalent changes and alterations made to the above compositions based on the technical essence of the present invention without departing from the scope of the present invention shall still fall within the scope of the present invention.

Claims

1. A composition containing an antibacterial and acne-reducing cyclic peptide, characterized in that, By weight, it includes the following components: Antibacterial and acne-reducing cyclic peptide: 7-9 parts; Pansy extract: 12-17 parts; Isatis indigotica extract: 5-7 parts; Soapberry extract: 15-21 parts.

2. The composition according to claim 1, characterized in that, By weight, it includes the following components: Antibacterial and acne-reducing cyclic peptide: 8 parts; Pansy extract: 15 parts; Isatis indigotica extract: 6 parts; Duck soap tree extract: 17 parts.

3. The use of the composition according to claim 1 or 2 in the preparation of cosmetics with antibacterial and acne-removing effects.

4. The application as described in claim 3, characterized in that, The cosmetic product is one of the following: toner, lotion, cream, mask, serum, or spray.

5. The application as described in claim 4, characterized in that, The composition is added to cosmetics in an amount of 0.5-10 wt%.

6. A serum with antibacterial and acne-removing effects, characterized in that, The serum contains the composition as described in claim 1 or 2.

7. The essence as described in claim 6, characterized in that, The composition is added to the serum in an amount of 1-5 wt%.

8. The serum as described in claim 6 or 7, characterized in that, The essence also contains at least one of the following: moisturizer, thickener, emulsifier, preservative, and solvent.